New Stock Arbitrage — Akumin Inc.

Here is a summary of our most recent Stock Arbitrage transaction that we have participated in . The stock involved were issued by Akumin Inc., one of the leading providers of outpatient diagnostic imaging services in the United States.

Since the trading volume of this stock was limited, the club only participated in a small portion. Short selling at $3.95 and repurchase at $3.90 to achieve a risk-free profit of $0.05 per share.

Akumin is a leading provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States with a network of 71 owned and/or operated imaging centers located in Florida, Pennsylvania, Delaware, Texas, Illinois and Kansas. By combining our clinical expertise with the latest advances in technology and information systems, our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. Our imaging procedures include MRI, CT, positron emission tomography (PET), ultrasound, diagnostic radiology (X-ray), mammography, and other interventional procedures.

Akumin Inc. announced that it has issued 8,750,000 shares of common stock to the public. The issuance price of the stock is set to be US$4.00, and the total fund-raising amount will be US$35,000,000. The Company intends to use the net proceeds from the offering to finance the cash consideration portion of the potential acquisition by a subsidiary of the Company of certain outstanding non-controlling interests in seven of the Company’s existing Texas-based diagnostic imaging centers (the “NCI Acquisition”) , being approximately $17.9 million; to support the Company’s growth initiatives and the acquisitions it pursues from time to time; and for general corporate purposes, including to fund other ordinary course expenses

Stock Name Akumin
Stock Symbol AKU.U
Exchange Toronto Stock Exchange
Issuer Akumin Inc.
Issue Size 8,750,000 shares of common stock and the total fund-raising amount will be US$35,000,000. The Underwriters shall have an over-allotment option up to an additional 1,312,500 Common Shares for additional gross proceeds of US$5,250,000.
Issue Price US$4.00
Closing Date On or about May 2, 2018
Underwriter Clarus Securities Inc.
Stock Type Bought deal offering by way of a short form prospectus, subject to the underwriting agreement, to be filed in the provinces of Canada, other than the Province of Québec. The Common Shares may be offered and sold in the United States pursuant to the exemption from the registration requirements of the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”)

We will notice all of our members next time when there is a stock arbitrage opportunity! For all the the detailed information regarding our arbitrage products or related business inquiries, please visited our website or send us a direct message!

93 Thoughts to “New Stock Arbitrage — Akumin Inc.”

  1. meloxicam 15mg tab 15

    meloxicam 15mg tab 15

  2. cialis costco

    cialis costco

  3. zithromax generic

    zithromax generic

  4. augmentin gen

    augmentin gen

  5. metronidazole spectrum

    metronidazole spectrum

  6. cephalexin k9

    cephalexin k9

  7. azithromycin strep

    azithromycin strep

  8. ciprofloxacin hydrochlorothiazide

    ciprofloxacin hydrochlorothiazide

  9. erythromycin ob

    erythromycin ob

  10. keflex bacteriocidal

    keflex bacteriocidal

  11. celebrex doses

    celebrex doses

  12. perfect

    thank you for a very good article


    […]here are some links to sites that we link to since we believe they’re worth visiting[…]

Comments are closed.